Chargement de l’entreprise
Just reported
Q3 2026 results
From Pfizer's results release of 3 novembre 2026; its quarterly report has since been filed.
Revenue
Actual
16,58B $US
-0,4 % y/y
+10 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,56 $US
-9,7 % y/y
Guided
—
No guide given
Company outlook
Full year 2026
- EPS, adjusted2,95 $US – 3,05 $USRaised +3,4 %
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Pfizer is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
LLYELI Lilly And Company1,35T $USA+
JNJJohnson & Johnson682,6B $USA+
MRKMerck & Co., Inc.362,2B $USA
NVSNovartis AG305,8B $USA
AMGNAmgen Inc.252,6B $USA+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
BIIBBiogen Inc.28 oct. 2026BAGraded B, now A
Comment elle gagne de l'argent
- Sales of its medicines and vaccines95 %
- Royalties3 %
- Contract manufacturing and drug ingredients2 %
- Research and development services0 %
Les parts du chiffre d'affaires sont des estimations pour year ended December 31, 2025, high confidence, pas des chiffres tirés d'un document officiel.
En concurrence avec
Ce qu'elle vend6
Eliquis
A prescription medicine that helps prevent blood clots and strokes in certain patients. Pfizer shares its development and commercial profits with Bristol Myers Squibb.
Pfizer vaccine portfolio
Vaccines include the Prevnar family for pneumococcal disease, Comirnaty to help prevent coronavirus disease, and Abrysvo for respiratory syncytial virus.
Paxlovid
A prescription medicine used to treat coronavirus disease.
Afficher 3 de plus
Oncology medicines
Cancer medicines include Ibrance for breast cancer, Padcev for bladder cancer, and Xtandi for prostate cancer.
Nurtec ODT and Vydura
Migraine medicines. ODT means orally disintegrating tablet.
Vyndaqel family
Medicines for transthyretin amyloidosis, a disease in which an abnormal protein builds up in the body and can damage the heart or nerves.
Qui l'achète4
- Wholesalers, which buy prescription medicines for resale to pharmacies, hospitals and other providers.
- Retailers, pharmacies, hospitals and clinics, which buy medicines directly for patients or for use in care.
- Government agencies and health institutions, which buy vaccines and medicines through contracts or purchasing programs.
- Insurers and pharmacy benefit managers, which negotiate rebates and decide which medicines are covered or preferred on their drug lists.
Sur quoi elle repose, et ce qui pourrait la briser
Ce dont l'activité dépend
- 1Revenue depends on continued sales of major medicines and vaccines; generic competition after patent or regulatory exclusivity ends can reduce sales.
- 2Some important products rely on partnerships: Pfizer shares profits from Comirnaty with BioNTech and from Eliquis with Bristol Myers Squibb, among other collaborations.
- 3Sales depend on wholesalers and other distribution channels, and on insurers and pharmacy benefit managers covering products and setting their place on medicine lists.
- 4Pfizer buys raw materials from suppliers worldwide and relies on manufacturing sites and supply chains to make and deliver products.
Ce qui pourrait mal tourner
- 1When patent protection or regulatory exclusivity ends, generic or biosimilar manufacturers can sell lower-priced alternatives. Pfizer says competition can quickly reduce sales of affected products.
- 2Government price-setting, required rebates and insurer demands can lower the prices Pfizer receives or limit access to its medicines. The Medicare price-negotiation program now sets a price Pfizer must offer for Eliquis.
- 3Drug development and regulatory approval can fail or change. Pfizer reported that a late-stage study of its investigational cancer medicine sigvotatug vedotin did not meet its main survival goal, and that it withdrew Oxbryta from the United States market after reviewing clinical and registry data.
À propos de Pfizer Inc.
Pfizer discovers, tests, manufactures, markets and sells medicines and vaccines around the world. Its products address conditions including cancer, heart and blood-vessel diseases, migraine, infections, immune disorders and rare diseases. It also makes medicines and drug ingredients for other companies and is winding down a research-services business for biotechnology companies.
- Siège
- New York City, New York
- Fondée en
- 1849 (company founded, high confidence)
- Effectif
- 75,000 (December 31, 2025, high confidence)
- Cotée sur
- NYSE
- Clôture de l'exercice
- December 31
Construit à partir des documents déposés par Pfizer Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
